Our data have also confirmed Cyclin E1 overexpression as a predictor of sensitivity to azenosertib monotherapy in PROC, and we intend to pursue further development in this patient population.” ...
Xsight Labs, a leading fabless semiconductor company providing end-to-end connectivity solutions for next-generation hyperscale, edge, and AI data center networks, announced the tape-out of the E1, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback